The news of Piper Sandler maintaining an Overweight rating on Danimer Scientific and raising the price target from $7 to $8 is positive for the stock. This indicates that the analyst has a bullish outlook on the company's performance, which could lead to an increase in investor confidence and potentially drive the stock price higher in the short term.